BioSpace News Archive

According to the report, the global adrenocorticotropic hormone market was valued at US$ 1.47 Bn in 2018 and is projected to expand at a CAGR of ~4% from 2019 to 2027. Multiple applications and rise in number of patients with chronic diseases are the major factors anticipated to drive the global adrenocorticotropic hormone market from 2019 to 2027.

Inscopix announced a collaboration with Bruker Corporation for its new Multimodal Image Registration and Analysis platform.

Zhongchao Inc. (NASDAQ: ZCMD) (“Zhongchao” or the “Company”), a healthcare services company offering patient management, online healthcare information, professional training and educational services, today announced that it co-organized a virtual panel session with the Chinese Association of Health Education and Promotion for the China -Ru

Company Focus on Shareholder Value Creation, Cash Preservation, Expense Reduction, Workforce Efficiency and Operational Synergies

Anixa Biosciences, Inc. announced that the European Patent Office has issued an Intention to Grant notice for the first European patent covering Anixa’s novel CAR-T cancer treatment technology, which has been licensed from The Wistar Institute and is being developed at the Moffitt Cancer Center.

BridgeBio Pharma, Inc. (Nasdaq: BBIO) affiliate Phoenix Tissue Repair (PTR) today announced an upcoming presentation of interim data from an ongoing Phase 1/2 study of PTR-01 (BBP-589), an intravenously-administered recombinant collagen 7 protein replacement therapy for patients with recessive dystrophic epidermolysis bullosa (RDEB). The presentation will be made during the Society for Pediatric Dermatology’s (SPD) 45th Annual Meeting, to be held virtu

Sexton Biotechnologies and CCMI Galway collaborative effort leads to approval by EU regulatory authorities for the use of nLiven PR in the expansion of an allogeneic MSC therapeutic product to address corneal transplant rejection [10-July-2020] INDIANAPOLIS and GALWAY, Ireland , July 10, 2020 /PRNewswire/ -- The Centre for Cell Manufacturing Ireland (CCMI) at the Nat

Director General of the International Vaccine Institute (IVI) will speak to vaccine development and the role of contact tracing in combating coronavirus BOCA RATON, Fla.--( BUSINESS WIRE )-- Modernizing Medicine® , a leading healthcare technology company, is hosting a new installment in its thought leadership webinar series . The session, “World War C: Contact Tracing and the Hunt for a Vaccine,” will take place virtually on Tuesday, July 14 at 7 P

Full US use of ANDiS 350 extraction systems would increase US daily testing capacity by 25% 3D Med extraction capacity increased by 1,000,000 kits per week Extraction reagent and automation scarcity spiking as US COVID-19 PCR demand surges 3D Med system successfully completes ‘pool testing’ validation for ANDiS 350 Todos gains branding rights to 3D Med COVID-19 products in the United States REHOVOT, Israel, NEW YORK, NY and Shanghai, China, July 10, 2020 (GLOBE NEWSWIRE) --

Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) today announced call-in details for today’s investor conference call on Friday July 10 th 2020 at 4:15 PM Eastern time . The access information for the investor conference call is as follows: Domestic US/Canada – 1-(877) 830‑2586 Direct Toll / International - 1-(785) 424-1734 Program Title: NuGenerex Immuno‑Oncology ‑ Investor Conference Call Conference ID – 66974 Agenda